7-Methyl-6-(1-(6-(quinolin-3-yl)-1H-imidazo[4,5-b]pyrazin-1-yl)ethyl)quinoline

ID: ALA4536783

PubChem CID: 86566631

Max Phase: Preclinical

Molecular Formula: C26H20N6

Molecular Weight: 416.49

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cc1cc2ncccc2cc1C(C)n1cnc2ncc(-c3cnc4ccccc4c3)nc21

Standard InChI:  InChI=1S/C26H20N6/c1-16-10-23-19(7-5-9-27-23)12-21(16)17(2)32-15-30-25-26(32)31-24(14-29-25)20-11-18-6-3-4-8-22(18)28-13-20/h3-15,17H,1-2H3

Standard InChI Key:  DUFHSDMKVRQMJP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 37  0  0  0  0  0  0  0  0999 V2000
   30.1232   -1.3331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1221   -2.1526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8301   -2.5616    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.8283   -0.9242    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.5370   -1.3295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5417   -2.1481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3218   -2.3965    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.7991   -1.7314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3140   -1.0720    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.5788   -3.1722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0356   -3.7827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3791   -3.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6309   -4.1132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4304   -4.2787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9149   -2.7272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7137   -2.8890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9715   -3.6683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7737   -3.8333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.3189   -3.2200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0563   -2.4389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2548   -2.2776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4159   -2.5609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7083   -2.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7120   -3.7845    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.4166   -3.3748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9996   -3.3755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0008   -2.5577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2943   -2.1497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5862   -2.5582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5890   -3.3791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2961   -3.7834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0857   -4.7219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  7 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 17  2  0
 16 15  2  0
 15 12  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 22 23  2  0
 23 27  1  0
 26 24  1  0
 24 25  2  0
 25 22  1  0
  2 22  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 26  2  0
 13 32  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4536783

   7-Methyl-6-[1-(5-quinolin-3-ylimidazo[4,5-b]pyrazin-3-yl)ethyl]quinoline

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 416.49

Molecular Weight (Monoisotopic): 416.1749

AlogP: 5.51

#Rotatable Bonds: 3

Polar Surface Area: 69.38

Molecular Species: NEUTRAL

HBA: 6

HBD: ┄

#RO5 Violations: 1

HBA (Lipinski): 6

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 4.95

CX LogP: 4.74

CX LogD: 4.74

Aromatic Rings: 6

Heavy Atoms: 32

QED Weighted: 0.38

Np Likeness Score: -1.01

References

1. Zhao F, Zhang J, Zhang L, Hao Y, Shi C, Xia G, Yu J, Liu Y..  (2016)  Discovery and optimization of a series of imidazo[4,5-b]pyrazine derivatives as highly potent and exquisitely selective inhibitors of the mesenchymal-epithelial transition factor (c-Met) protein kinase.,  24  (18): [PMID:27448775] [10.1016/j.bmc.2016.07.019]

Source

Source(1):

• Scientific Literature